The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
European consensus conference on faecal microbiota transplantation in clinical practice
Open accessAbstract
Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile infection. Promising findings suggest that FMT may play a role also in the management of other disorders associated with the alteration of gut microbiota. Although the health community is assessing FMT with renewed interest and patients are becoming more aware, there are technical and logistical issues in establishing such a non-standardised treatment into the clinical practice with safety and proper governance. In view of this, an evidence-based recommendation is needed to drive the practical implementation of FMT. In this European Consensus Conference, 28 experts from 10 countries collaborated, in separate working groups and through an evidence-based process, to provide statements on the following key issues: FMT indications; donor selection; preparation of faecal material; clinical management and faecal delivery and basic requirements for implementing an FMT centre. Statements developed by each working group were evaluated and voted by all members, first through an electronic Delphi process, and then in a plenary consensus conference. The recommendations were released according to best available evidence, in order to act as guidance for physicians who plan to implement FMT, aiming at supporting the broad availability of the procedure, discussing other issues relevant to FMT and promoting future clinical research in the area of gut microbiota manipulation. This consensus report strongly recommends the implementation of FMT centres for the treatment of C. difficile infection as well as traces the guidelines of technicality, regulatory, administrative and laboratory requirements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current guidelines for FMT in clinical practice 14 recommendspecific protocols for donor screening aimed at assuring that the transplanted material is safe, primarily by avoiding the transfer of infectious agents.”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [14]
In the citing paper
“Current guidelines for donor screening recommend excluding individuals with cancer and chronic inflammatory or metabolic disorders, 14”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [14]
In the citing paper
“The European consensus proposed that the follow-up period after FMT in CDI patients should be at least 8 weeks, and the contents of follow-up must include clinical and analytical data.49”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
The Delphi Technique: Making Sense of Consensus
Hsu, C.-C., & Sandford, B. A. (2007) · University of Massachusetts Amherst · doi:10.7275/pdz9-th90 · Cited by 4,500
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Self-citationVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913 · cited 1×
“16 The global interest in FMT is increasing, and both doctors and patients are increasingly aware and informed.”
BackgroundBurden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., Kayser, B. D., Levenez, F., Chilloux, J., Hoyles, L., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308778 · Cited by 1,931
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499 · cited 1×
“1 57 68 68 In the study by Moayyedi et al , 15 rectal abscesses after via-enemas infusion of faeces or placebo were reported in patients with UC.”
BackgroundProton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371
Research works printed but not linked: 4
- Kump, 2014, Recommendations for the use of faecal microbiota transplantation “stool transplantation”: consensus of the Austrian Society of Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society of Infectious Diseases and Tropical Medicine, Z Gastroenterol, 52, 1485
- Kump, 2013, Preliminary clinical results of repeatedly fecal microbiota transplantation (FMT) in chronic active ulcerative colitis [abstract], United European Gastroenterol J, 1S, A57
- 10.1093/ecco-jcc/jju027.450 · doi:10.1093/ecco-jcc/jju027.450
- 10.1093/ecco-jcc/jjw019.016 · doi:10.1093/ecco-jcc/jjw019.016
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Baruch, E. N., Youngster, I., Ben-Betzalel, G., Ortenberg, R., Lahat, A., Katz, L., Adler, K., Dick-Necula, D., Raskin, S., Bloch, N., et al. (2021) · Science · doi:10.1126/science.abb5920 · Cited by 1,757
Human gut microbiota/microbiome in health and diseases: a review
Gomaa, E. Z. (2020) · Antonie van Leeuwenhoek · doi:10.1007/s10482-020-01474-7 · Cited by 1,294
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910437 · Cited by 1,281
Metadata
- Authors
- Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., Segal, J., Aloi, M., Masucci, L., Molinaro, A., Scaldaferri, F., Gasbarrini, G., Lopez-Sanroman, A., Link, A., de Groot, P., de Vos, W. M., Högenauer, C., Malfertheiner, P., Mattila, E., Milosavljević, T., Nieuwdorp, M., Sanguinetti, M., Simren, M., & Gasbarrini, A.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Innsbruck Medical University (AT)
- University of Belgrade (RS)
- University of Graz (AT)
- University of Helsinki (FI)
- Assistance Publique – Hôpitaux de Paris (FR)
- Tissues and Cells Area, Italian National Transplant Center (CNT), Rome, Italy
- St Mark's Hospital (GB)
- Sapienza University of Rome (IT)
- University of Gothenburg (SE)
- Department of Gastroenterological Area, “A. Gemelli” Hospital, Catholic University of the Sacred Heart, Rome, Italy
- Gastroenterology and Hepatology Service, Ramón y Cajal University Hospital, Madrid, Spain
- University Hospital Magdeburg (DE)
- Department of Internal Medicine, Academic University Medical Center, Amsterdam, The Netherlands
- Faculty of Medicine, Immunobiology Research Program, Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
- Helsinki University Hospital (FI)
- Amsterdam UMC Location University of Amsterdam (NL)
- Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
- Corresponding author
- Cammarota, Giovanni
- ORCID
- Cammarota, Giovanni
- Ianiro, Gianluca
- Tilg, Herbert
- Rajilić-Stojanović, Mirjana
- Satokari, Reetta
- Sokol, Harry
- Hart, Ailsa
- Segal, Jonathan
- Aloi, Marina
- Masucci, Luca
- Molinaro, Antonio
- Scaldaferri, Franco
- Link, Alexander
- Högenauer, Christoph
- Malfertheiner, Peter
- Milosavljević, Tomica
- Nieuwdorp, Max
- Sanguinetti, Maurizio
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2017-01-13
- Volume
- 66
- Issue
- 4
- Pages
- 569-580
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC5529972
- OpenAlex
- W2571820890
- Cited by
- 1,207
- References
- 91
- Citations by year
- 2026: 120 · 2025: 132 · 2024: 113 · 2023: 126 · 2022: 155 · 2021: 135 · 2020: 173 · 2019: 114 · 2018: 94 · 2017: 42
- FWCI
- 89.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- TechnoRep (University of Belgrade – Faculty of Technology and Metallurgy) (publishedVersion, other-oa)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by-nc)
- HAL (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc)
- Funders
- ZonMw (016.146.327)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, Clostridium difficile infection, gut microbiota, donor selection, regulatory requirements
- MeSH terms
- Fecal Microbiota Transplantation, Enterocolitis, Pseudomembranous, Europe, Health Facilities, Hospital Units, Humans, Specimen Handling, Clostridioides difficile, Patient Selection, Evidence-Based Medicine, Donor Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: European consensus conference on faecal microbiota transplantation in clinical practice. https://app.cochat.ai/papers/10.1136/gutjnl-2016-313017
- The paper
- Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., Segal, J., Aloi, M., Masucci, L., Molinaro, A., Scaldaferri, F., Gasbarrini, G., Lopez-Sanroman, A., Link, A., de Groot, P., . . . Gasbarrini, A. (2017). European consensus conference on faecal microbiota transplantation in clinical practice. Gut. https://doi.org/10.1136/gutjnl-2016-313017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.